Alaska Heart Institute

Anchorage, Alaska 99508

1 studies enrolling now · 21 studies all time

What they study most

Angina Pectoris, Arrhythmia, Atrial Fibrillation, Atrial Fibrillation New Onset, Atrial Flutter, Bradycardia, CAD, CHD, CIED Related Infection, CVD, Cardiovascular Disease, Cardiovascular Diseases

Studies at this site

• STOP AF First Post-Approval Study — Recruiting now
• A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
• PRE-DETERMINE Cohort Study — Running, not enrolling
• STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation — Completed
• Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS) — Completed
• Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation — Completed
• St. Jude Medical Product Longevity and Performance (SCORE) Registry — Completed
• Lead Registry for Optim Leads — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Vest Prevention of Early Sudden Death Trial and VEST Registry — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• QuickFlex Micro Left Ventricular Lead Post Approval Study — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree — Completed
• Study of New Implantable Loop Recorder — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Diagnostic Investigation of Sudden Cardiac Event Risk — Completed
• REASSURE AV Registry — Completed
• Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study — Completed